Advertisement

Perinatal Tumors

  • Richard G. AzizkhanEmail author
  • Daniel von Allmen
Chapter

Abstract

Malignant tumors diagnosed during the neonatal period are rarely encountered but extremely difficult to manage. Because factors such as drug absorption, metabolism, distribution, and elimination are affected by age and physiologic maturity, complications associated with the immature physiology of the neonate are common. Age-dependent maturation of the renal, hepatic, hematopoietic, and neurodevelopmental systems make the neonate particularly vulnerable to the deleterious effects of aggressive multimodal therapy involving extirpative surgery, chemotherapy, and radiotherapy. In addition, many neonatal malignancies differ from similar tumors in older children with respect to their biological behavior. These combined factors make tumors in the neonatal period a unique clinical domain and a domain in which most clinicians have little experience. The chapter provides an overview of the clinical presentation, diagnosis, and management of the most frequently seen, though rare, perinatal neoplasms.

Keywords

Neonatal tumors Perinatal neoplasms 

References

  1. 1.
    Bader JL, Miller RW. US cancer incidence and mortality in the first year of life. Am J Dis Child. 1979;133:157–9.PubMedGoogle Scholar
  2. 2.
    Littman P, D’Angio GJ. Radiation therapy in the neonate. Am J Pediatr Hematol Oncol. 1981;3:279–85.PubMedGoogle Scholar
  3. 3.
    Reaman GH, Bleyer A. Infants and adolescents with cancer: special considerations, chap 15. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.Google Scholar
  4. 4.
    Bhatia S, Landier W, Robison LL. Late effects of childhood cancer therapy. In: DeVita VT, Hellman S, Rosenberg SA, editors. Progress in oncology. Sudbury: Jones and Bartlett Publishers; 2002. p. 171–213.Google Scholar
  5. 5.
    Pintér AB, Hock A, Kajtár P, Dober I. Long-term follow-up of cancer in neonate and infants: a national survey of 142 patients. Pediatr Surg Int. 2003;19:233–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Meadows AT, Gallagher JA, Bunin GR. Late effects of early childhood cancer therapy. Br J Cancer Suppl. 1992;18:S92–5.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms’ tumor. Int J Radiat Oncol Biol Phys. 2000;46:1239–46.PubMedCrossRefGoogle Scholar
  8. 8.
    Dreyer ZE, Blatt J, Bleyer A. Late effects of childhood cancer and its treatment, chap 49. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.Google Scholar
  9. 9.
    Robison LL. The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer. Minn Med. 2005;88:45–9.PubMedGoogle Scholar
  10. 10.
    Crom DB, Wilimas JA, Green AA, Pratt CB, Jenkins 3rd JJ, Behm FG. Malignancy in the neonate. Med Pediatr Oncol. 1989;17:101–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Campbell AN, Chan HS, O’Brien A, Smith CR, Becker LE. Malignant tumors in the neonate. Arch Dis Child. 1988;62:19–23.CrossRefGoogle Scholar
  12. 12.
    Batcup G. Cancer in the very young child—pitfalls and problems for the pathologist. Br J Cancer. 1992;18(Suppl):S5–7.Google Scholar
  13. 13.
    Xue H, Horwitz JR, Smith MB, et al. Malignant solid tumors in neonates: a 40-year review. J Pediatr Surg. 1995;30:543–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Moore SW, Kaschula ROC, Albertyn R, Rode H, Millar AJW, Karabus C. The outcome of solid tumours occurring in the neonatal period. Pediatr Surg Int. 1995;10:366–70.Google Scholar
  15. 15.
    Dillon PW, Azizkhan RG. Neonatal tumors, chap 19. In: Andrassy RJ, editor. Pediatric surgery oncology. Philadelphia: WB Saunders Co; 1997.Google Scholar
  16. 16.
    Parkes SE, Muir KR, Southern L, Cameron AH, Darbyshire PJ, Stevens MC. Neonatal tumors: a thirty-year population-based study. Med Pediatr Oncol. 1994;22:309–17.PubMedCrossRefGoogle Scholar
  17. 17.
    Halperin EC. Neonatal neoplasms. Int J Radiat Oncol Biol Phys. 2000;47:171–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Moore SW, Plaschkes J. Epidemiology and genetic associations of neonatal tumors, chap 70. In: Puri P, editor. Newborn surgery. 2nd ed. New York: Oxford University Press Inc; 2003.Google Scholar
  19. 19.
    Buyukpamukcu M, Varan A, Tanyel C, et al. Solid tumors in the neonatal period. Clin Pediatr. 2003;42:29–34.CrossRefGoogle Scholar
  20. 20.
    Moore SW, Satgé D, Sasco AJ, Zimmermann A, Plaschkes J. The epidemiology of neonatal tumours: report of an international working group. Pediatr Surg Int. 2003;19:509–19.PubMedCrossRefGoogle Scholar
  21. 21.
    Moore SW. Genetic and clinical associations of neonatal tumours. In: Puri P, editor. Neonatal tumours. New York: Springer; 1996. p. 11–22.CrossRefGoogle Scholar
  22. 22.
    Altmann AE, Halliday JL, Giles GG. Associations between congenital malformations and childhood cancer: a register-based case-control study. Br J Cancer. 1998;78:1244–9.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Satgé D, Van Den Berghe H. Aspects of the neoplasms observed in patients with constitutional autosomal trisomy. Cancer Genet Cytogenet. 1996;87:63–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Coppes MJ, Campbell CE, Williams BR. The role of WT1 in Wilms tumorigenesis. FASEB J. 1993;7:886–95.PubMedGoogle Scholar
  25. 25.
    Holland WW, Doll R, Carter CO. The mortality from leukaemia and other cancers among patients with Down’s syndrome (Mongols) and among their parents. Br J Cancer. 1962;16:177–86.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Weinberg AG, Schiller G, Windmiller J. Neonatal leukemoid reaction. An isolated manifestation of mosaic Trisomy 21. Am J Dis Child. 1982;136:310–1.PubMedCrossRefGoogle Scholar
  27. 27.
    Bresters D, Reus AC, Veerman AJ, van Wering AR, van der Does-van den Berg A, Kaspers GJ. Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol. 2002;117:513–24.PubMedCrossRefGoogle Scholar
  28. 28.
    Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;79:130–9.CrossRefGoogle Scholar
  29. 29.
    Rahbar R, Vogel A, Myers LB, et al. Fetal surgery in otolaryngology: a new era in the diagnosis and management of fetal airway obstruction because of advances in prenatal imaging. Arch Otolaryngol Head Neck Surg. 2005;131:393–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Coleman BG, Adzick NS, Crombleholme TM, et al. Fetal therapy: state of the art. J Ultrasound Med. 2002;21:1257–88.PubMedGoogle Scholar
  31. 31.
    Sauvat F, Sarnacki S, Brisse H, et al. Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer. 2002;94:2474–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Lund DP, Soriano SG, Fauza D, et al. Resection of a massive sacrococcygeal teratoma using hypothermic hypoperfusion: a novel use for extracorporeal membrane oxygenation. J Pediatr Surg. 1995;30:1557–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Mychaliska GB, Bealer JF, Graf JL, Rosen MA, Adzick NS, Harrison MR. Operating on placental support: the ex utero intrapartum treatment procedure. J Pediatr Surg. 1997;32:227–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Wegner EA, Barrington SF, Kingston JE, et al. The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging. 2005;32:23–30.PubMedCrossRefGoogle Scholar
  35. 35.
    Rechnitzer C. Increased survival of children with solid tumours: how did we get there and how to keep the success going? Cancer Imaging. 2011;11(Spec No A):S65–9.Google Scholar
  36. 36.
    Kumar R, Shandal V, Shamim SA, et al. Clinical applications of PET and PET/CT in pediatric malignancies. Expert Rev Anticancer Ther. 2010;10:755–68.PubMedCrossRefGoogle Scholar
  37. 37.
    Brodeur GM, Maris JM. Neuroblastoma, chap 31. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.Google Scholar
  38. 38.
    Silber JH, Littman PS, Meadows AT. Stature loss following skeletal irradiation for childhood cancer. J Clin Oncol. 1990;8:304–12.PubMedGoogle Scholar
  39. 39.
    Meadows AT, Gordon J, Massari DJ, Littman P, Fergusson J, Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet. 1981;2:1015–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Farwell JR, Dohrmann GJ, Flannery JT. Intracranial neoplasms in infants. Arch Neurol. 1978;35:533–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Littman PS, D’Angio GJ. Growth considerations in the radiation therapy of children with cancer. Annu Rev Med. 1979;30:405–15.PubMedCrossRefGoogle Scholar
  42. 42.
    Guibout C, Adjadj E, Rubino C, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol. 2005;23:197–204.PubMedCrossRefGoogle Scholar
  43. 43.
    Maier JG. Effects of radiation on kidney, bladder and prostate. In: Vaeth JM, editor. Frontiers of radiation therapy and oncology, vol. 6. Baltimore: Karger, Basel and University Park Press; 1972. p. 196–207.Google Scholar
  44. 44.
    Kraut JW, Bagshaw MA, Glatsein EJ. Hepatic effects of irradiation. In: Vaeth JM, editor. Frontiers of radiation therapy and oncology, vol. 6. Baltimore: Karger, Basel and University Park Press; 1972. p. 182–95.Google Scholar
  45. 45.
    Cancer pharmacology in infants and young children. Online summary of meeting sponsored by the Children’s Oncology Group (COG) and National Cancer Institute-Cancer Therapy Evaluation Program (CTEP), Arlington; 2003.Google Scholar
  46. 46.
    Morgan E, Baum E, Breslow N, Takashima J, D’Angio G. Chemotherapy-related toxicity in infants treated according to the Second National Wilms’ Tumor Study. J Clin Oncol. 1988;6:51–5.PubMedGoogle Scholar
  47. 47.
    Lobe TE, Wiener ES, Hays DM, et al. Neonatal rhabdomyosarcoma: the IRS experience. J Pediatr Surg. 1994;29:1167–70.PubMedCrossRefGoogle Scholar
  48. 48.
    Reaman G, Zeltzer P, Bleyer WA, et al. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children’s Cancer Study Group. J Clin Oncol. 1985;3:1513–21.PubMedGoogle Scholar
  49. 49.
    Isaacs Jr H. Perinatal (fetal and neonatal) germ cell tumors. J Pediatr Surg. 2004;39:1003–13.PubMedCrossRefGoogle Scholar
  50. 50.
    Shamberger RC. Teratomas and germ cell tumors, chap 24. In: O’Neill JA, Grosfeld JL, Fonkalsrud EW, et al., editors. Principles of pediatric surgery. 2nd ed. St. Louis: Mosby; 2004.Google Scholar
  51. 51.
    Azizkhan RG. Teratomas and other germ cell tumors, chap 34. In: Grosfeld JL, O’Neill JA, Coran AG, Fonkalsrud EW, editors. Pediatric surgery. 6th ed. Philadelphia: Mosby Inc; 2006.Google Scholar
  52. 52.
    Bale PM. Sacrococcygeal developmental abnormalities and tumors in children. Perspect Pediatr Pathol. 1984;8:9–56.PubMedGoogle Scholar
  53. 53.
    Lemire RJ, Beckwith JB. Pathogenesis of congenital tumors and malformations of the sacrococcygeal region. Teratology. 1982;25:201–13.PubMedCrossRefGoogle Scholar
  54. 54.
    Noseworthy J, Lack EE, Kozakewich HP, Vawter GF, Welch KJ. Sacrococcygeal germ cell tumors in childhood: an updated experience with 118 patients. J Pediatr Surg. 1981;16:358–64.PubMedCrossRefGoogle Scholar
  55. 55.
    Gonzalez-Crussi F. Extragonadal teratomas. In: Atlas of tumor pathology. 2nd series. Washington, DC: Armed Forces Institute of Pathology; US Gov Priniting, 1982: fascicle 18.Google Scholar
  56. 56.
    Sen G, Sebire NJ, Olsen O, et al. Familial Currarino syndrome presenting with peripheral primitive neuroectodermal tumour arising with a sacral teratoma. Pediatr Blood Cancer. 2008;50:172–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Cushing B, Perlman EJ, Marina NM, Castleberry RP. Germ cell tumors, chap 36. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.Google Scholar
  58. 58.
    Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37:2359–72.PubMedCrossRefGoogle Scholar
  59. 59.
    Robboy SJ, Scully RE. Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Hum Pathol. 1970;1:643–53.PubMedCrossRefGoogle Scholar
  60. 60.
    Isaacs Jr H. Germ cell tumors. In: Tumors of the fetus and newborn, Major problems in pathology series, vol. 35. Philadelphia: WB Saunders; 1997. p. 15.Google Scholar
  61. 61.
    Valdiserri RO, Yunis EJ. Sacrococcygeal teratomas: a review of 68 cases. Cancer. 1981;48:217–21.PubMedCrossRefGoogle Scholar
  62. 62.
    Baumann FR, Nerlich A. Metastasizing cervical teratoma of the fetus. Pediatr Pathol. 1993;13:21–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Dehner LP, Mills A, Talerman A, Billman GF, Krous HF, Platz CE. Germ cell neoplasms of head and neck soft tissues: a pathologic spectrum of teratomatous and endodermal sinus tumors. Hum Pathol. 1990;21:309–18.PubMedCrossRefGoogle Scholar
  64. 64.
    Heifetz SA, Cushing B, Giller R, et al. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children’s Cancer Group. Am J Surg Pathol. 1998;22:1115–24.PubMedCrossRefGoogle Scholar
  65. 65.
    Tsuchida Y, Endo Y, Saito S, et al. Evaluation of alpha fetoprotein in early infancy. J Pediatr Surg. 1978;13:155–62.PubMedCrossRefGoogle Scholar
  66. 66.
    Schneider DT, Calaminus G, Göbel U. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood. Pediatr Hematol Oncol. 2001;18:11–26.PubMedCrossRefGoogle Scholar
  67. 67.
    Rowe MI, O’Neill JA, Grosfeld JL, Fonkalsrud EW, Coran AG. Teratomas and germ cell tumors, chap 30. In: Rowe MI, O’Neill JA, Grosfeld JL, Fonkalsrud EW, Coran AG, editors. Essentials of pediatric surgery. St Louis: Mosby-Year Book; 1995.Google Scholar
  68. 68.
    Magee JF, McFadden DE, Pantzar JT. Congenital tumors. In: Dimmick JE, Kalousek DK, editors. Developmental pathology of the embryo and fetus. Philadelphia: JB Lippincott; 1992. p. 235.Google Scholar
  69. 69.
    Schropp KP, Lobe TE, Rao B, et al. Sacrococcygeal teratoma: the experience of four decades. J Pediatr Surg. 1992;27:1075–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Goto M, Makino Y, Tamura R, Ikeda S, Kawarabayashi T. Sacrococcygeal teratoma with hydrops fetalis and bilateral hydronephrosis. J Perinat Med. 2000;28:414–8.PubMedGoogle Scholar
  71. 71.
    Rescorla FJ, Sawin RS, Coran AG, Dillon PW, Azizkhan RG. Long-term outcome for infants and children with sacrococcygeal teratoma: a report from the Children’s Cancer Group. J Pediatr Surg. 1998;33:171–6.PubMedCrossRefGoogle Scholar
  72. 72.
    Werb P, Scurry J, Ostor A, Fortune D, Attwood H. Survey of congenital tumors in perinatal necropsies. Pathology. 1992;24:247–53.PubMedCrossRefGoogle Scholar
  73. 73.
    Altman RP, Randolph JG, Lilly JR. Sacrococcygeal teratoma: american academy of pediatrics surgical section survey–1973. J Pediatr Surg. 1974;9:389–98.PubMedCrossRefGoogle Scholar
  74. 74.
    Carney JA, Thompson DP, Johnson CL, Lynn HB. Teratomas in children: clinical and pathologic aspects. J Pediatr Surg. 1972;7:271–82.PubMedCrossRefGoogle Scholar
  75. 75.
    Fraumeni Jr JF, Li FP, Dalager N. Teratomas in children: epidemiologic features. J Natl Cancer Inst. 1973;51:1425–30.PubMedGoogle Scholar
  76. 76.
    Hawkins E, Perlman EJ. Germ cell tumors, chap 10. In: Parham DM, editor. Pediatric neoplasia: morphology and biology. Philadelphia: Lippincott-Raven; 1996.Google Scholar
  77. 77.
    Garel C, Mizouni L, Menez F, et al. Prenatal diagnosis of a cystic type IV sacrococcygeal teratoma mimicking a cloacal anomaly: contribution of MR. Prenat Diagn. 2005;25:216–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Yoon SH, Park SH. A case of type III cystic sacrococcygeal teratoma. Pediatr Neurosurg. 2006;42:234–6.PubMedCrossRefGoogle Scholar
  79. 79.
    Danzer E, Hubbard AM, Hedrick HL, et al. Diagnosis and characterization of fetal sacrococcygeal teratoma with prenatal MRI. AJR Am J Roentgenol. 2006;187:W350–6.PubMedCrossRefGoogle Scholar
  80. 80.
    Shaaban AF, Kim HB, Flake AW. Fetal surgery, diagnosis, and intervention, chap 3. In: Ziegler MM, Azizkhan RG, Weber TR, editors. Operative pediatric surgery. New York: McGraw-Hill; 2003.Google Scholar
  81. 81.
    Bianchi DW, Crombleholme TM, D’Alton ME. Fetology: diagnosis and management of the fetal patient. New York: McGraw-Hill; 2000. Chap 111, Chap 116.Google Scholar
  82. 82.
    Flake AW. Fetal sacrococcygeal teratoma. Semin Pediatr Surg. 1993;2:113–20.PubMedGoogle Scholar
  83. 83.
    Kapoor R, Saha MM. Antenatal sonographic diagnosis of fetal sacrococcygeal teratoma with hydrops. Australas Radiol. 1989;33:285–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Hedrick HL, Flake AW, Crombleholme TM, et al. Sacrococcygeal teratoma: prenatal assessment, fetal intervention, and outcome. J Pediatr Surg. 2004;39:430–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Bond SJ, Harrison MR, Schmidt KG, et al. Death due to high-output cardiac failure in fetal sacrococcygeal teratoma. J Pediatr Surg. 1990;25:1287–91.PubMedCrossRefGoogle Scholar
  86. 86.
    Flake AW, Harrison MR, Adzick NS, et al. Fetal sacrococcygeal teratoma. J Pediatr Surg. 1986;21:563–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Musci Jr MN, Clark MJ, Ayres RE, Finkel MA. Management of dystocia caused by a large sacrococcygeal teratoma. Obstet Gynecol. 1983;62:10s–2.PubMedGoogle Scholar
  88. 88.
    Roybal JL, Moldenhauer JS, Khalek N, et al. Early delivery as an alternative management strategy for selected high-risk fetal sacrococcygeal teratomas. J Pediatr Surg. 2011;46:1325–32.PubMedCrossRefGoogle Scholar
  89. 89.
    Adzick NS, Crombleholme TM, Morgan MA, Quinn TM. A rapidly growing fetal teratoma. Lancet. 1997;349:538.PubMedCrossRefGoogle Scholar
  90. 90.
    Azizkhan RG. Neonatal tumors, chap 8. In: Carachi R, Azmy A, Grosfeld JL, editors. The surgery of childhood tumors. New York: Oxford University Press; 1999.Google Scholar
  91. 91.
    Fishman SJ, Jennings RW, Johnson SM, Kim HB. Contouring buttock reconstruction after sacrococcygeal teratoma resection. J Pediatr Surg. 2004;39:439–41.PubMedCrossRefGoogle Scholar
  92. 92.
    Gross RW, Clatworthy Jr HW, Meeker Jr IA. Sacrococcygeal teratomas in infants and children: a report of 40 cases. Surg Gynecol Obstet. 1951;92:341–54.PubMedGoogle Scholar
  93. 93.
    Robertson FM, Crombleholme TM, Frantz 3rd ID, Shephard BA, Bianchi DW, D’Alton ME. Devascularization and staged resection of giant sacrococcygeal teratoma in the premature infant. J Pediatr Surg. 1995;30:309–11.PubMedCrossRefGoogle Scholar
  94. 94.
    Teitelbaum D, Teich S, Cassidy S, Karp M, Cooney D, Besner G. Highly vascularized sacrococcygeal teratoma: description of this atypical variant and its operative management. J Pediatr Surg. 1994;29:98–101.PubMedCrossRefGoogle Scholar
  95. 95.
    Göbel U, Schneider DT, Calaminus G, et al. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. J Clin Oncol. 2001;19:1943–50.PubMedGoogle Scholar
  96. 96.
    Göbel U, Calaminus G, Schneider DT, Schmidt P, Haas RJ. Management of germ cell tumors in children: approaches to cure. Onkologie. 2002;25:14–22.PubMedCrossRefGoogle Scholar
  97. 97.
    Rescorla F, Billmire D, Stolar C, et al. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882). J Pediatr Surg. 2001;36:12–7.PubMedCrossRefGoogle Scholar
  98. 98.
    Misra D, Pritchard J, Drake DP, Kiely EM, Spitz L. Markedly improved survival in malignant sacrococcygeal teratomas—16 years’ experience. Eur J Pediatr Surg. 1997;7:152–5.PubMedCrossRefGoogle Scholar
  99. 99.
    Calaminus G, Schneider DT, Bokkerink JP, et al. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89. J Clin Oncol. 2003;21:781–6.PubMedCrossRefGoogle Scholar
  100. 100.
    Donnellan WA, Swenson O. Benign and malignant sacrococcygeal teratomas. Surgery. 1968;64:834–46.PubMedGoogle Scholar
  101. 101.
    Waldhausen JA, Kolman JW, Vellios F, Battersby JS. Sacrococcygeal teratoma. Surgery. 1963;54:933–49.PubMedGoogle Scholar
  102. 102.
    Marina NM, Cushing B, Giller R, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol. 1999;17:2137–43.PubMedGoogle Scholar
  103. 103.
    Azizkhan RG, Caty MG. Teratomas in childhood. Curr Opin Pediatr. 1996;8:287–92.PubMedCrossRefGoogle Scholar
  104. 104.
    Azizkhan RG, Haase GM, Applebaum H, et al. Diagnosis, management, and outcome of cervicofacial teratomas in neonates: a Children’s Cancer Group Study. J Pediatr Surg. 1995;30:312–6.PubMedCrossRefGoogle Scholar
  105. 105.
    Lack EE. Extragonadal germ cell tumors of the head and neck region: review of 16 cases. Hum Pathol. 1985;16:56–64.PubMedCrossRefGoogle Scholar
  106. 106.
    Gundry SR, Wesley JR, Klein MD, Barr M, Coran AG. Cervical teratomas in the newborn. J Pediatr Surg. 1983;18:382–6.PubMedCrossRefGoogle Scholar
  107. 107.
    Batsakis JG, Littler ER, Oberman HA. Teratomas of the neck. A clinicopathologic appraisal. Arch Otolaryngol. 1964;79:619–24.PubMedCrossRefGoogle Scholar
  108. 108.
    Jordan RB, Gauderer MW. Cervical teratomas: an analysis, literature review and proposed classification. J Pediatr Surg. 1988;23:583–91.PubMedCrossRefGoogle Scholar
  109. 109.
    Liechty KW, Hedrick HL, Hubbard AM, et al. Severe pulmonary hypoplasia associated with giant cervical teratomas. J Pediatr Surg. 2006;41:230–3.PubMedCrossRefGoogle Scholar
  110. 110.
    Elmasalme F, Giacomantonio M, Clarke KD, Othman E, Matbouli S. Congenital cervical teratoma in neonates. Case report and review. Eur J Pediatr Surg. 2000;10:252–7.PubMedCrossRefGoogle Scholar
  111. 111.
    Sbragia L, Paek BW, Feldstein VA, et al. Outcome of prenatally diagnosed solid fetal tumors. J Pediatr Surg. 2001;36:1244–7.PubMedCrossRefGoogle Scholar
  112. 112.
    De Backer A, Madern GC, van de Ven CP, Tibboel D, Hazebroek FW. Strategy for management of newborns with cervical teratoma. J Perinat Med. 2004;32:500–8.PubMedGoogle Scholar
  113. 113.
    Langer JC, Tabb T, Thompson P, Paes BA, Caco CC. Management of prenatally diagnosed tracheal obstruction: access to the airway in utero prior to delivery. Fetal Diagn Ther. 1992;7:12–6.PubMedCrossRefGoogle Scholar
  114. 114.
    Touran T, Applebaum H, Frost DB, Richardson R, Taber P, Rowland J. Congenital metastatic cervical teratoma: diagnostic and management considerations. J Pediatr Surg. 1989;24:21–3.PubMedCrossRefGoogle Scholar
  115. 115.
    Buckley NJ, Burch WM, Leight GS. Malignant teratoma in the thyroid gland of an adult: a case report and a review of the literature. Surgery. 1986;100:932–7.PubMedGoogle Scholar
  116. 116.
    Mahour GH, Landing BH, Woolley MM. Teratomas in children: clinico-pathologic studies in 133 patients. Z Kinderchir. 1978;23:365–80.Google Scholar
  117. 117.
    Gatcombe HG, Assikis V, Kooby D, Johnstone PA. Primary retroperitoneal teratomas: a review of the literature. J Surg Oncol. 2004;86:107–13.PubMedCrossRefGoogle Scholar
  118. 118.
    Auge B, Satge D, Sauvage P, Lutz P, Chenard MP, Levy JM. Retroperitoneal teratomas in the perinatal period. Review of the literature concerning a neonatal, immature, aggressive teratoma. Ann Pediatr (Paris). 1993;40:613–21.Google Scholar
  119. 119.
    Fagiana AM, Barnett S, Reddy S. Management of a fetal intrapericardial teratoma: a case report and review of the literature. Congenit Heart Dis. 2010;5:51–5.PubMedCrossRefGoogle Scholar
  120. 120.
    Goldberg SP, Boston US, Turpin DA, et al. Surgical Management of intrapericardial teratoma in the fetus. J Pediatr. 2010;156:848–9.PubMedCrossRefGoogle Scholar
  121. 121.
    Azizkhan RG. Perinatal tumors. In: Carachi R, Grosfeld J, Azmy A, editors. The surgery of childhood tumors. 2nd ed. Berlin: Springer; 2008. p. 145–67.CrossRefGoogle Scholar
  122. 122.
    Isaacs Jr H. Perinatal (congenital and neonatal) neoplasms: a report of 110 cases. Pediatr Pathol. 1985;3:165–216.PubMedCrossRefGoogle Scholar
  123. 123.
    Dehner LP. Neoplasms of the fetus and neonate. In: Naeye RL, Kissane JM, Kaufman N, editors. Perinatal diseases. International academy of pathology monograph number 22. Baltimore: Williams and Wilkins; 1981. p. 286–345.Google Scholar
  124. 124.
    Beckwith JB, Perrin EV. In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol. 1963;43:1089–104.PubMedPubMedCentralGoogle Scholar
  125. 125.
    Guin GH, Gilbert EF, Jones B. Incidental neuroblastoma in infants. Am J Clin Pathol. 1969;51:126–36.PubMedCrossRefGoogle Scholar
  126. 126.
    Woods WG, Lemieux B, Tuchman M. Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma Screening Project. Pediatrics. 1992;89:114–8.PubMedGoogle Scholar
  127. 127.
    Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991;9:581–91.PubMedGoogle Scholar
  128. 128.
    Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997;19:93–101.PubMedCrossRefGoogle Scholar
  129. 129.
    Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111–6.PubMedCrossRefGoogle Scholar
  130. 130.
    Azizkhan RG, Haase GM, Coran AG, et al. Diagnosis, management and outcome of neuroblastoma in neonates: a Children’s Cancer Group study. 36th World Congress of Surgery abstract book; Lisban, Portugal, 1995. p. 134.Google Scholar
  131. 131.
    Richards ML, Gundersen AE, Williams MS. Cystic neuroblastoma of infancy. J Pediatr Surg. 1995;30:1354–7.PubMedCrossRefGoogle Scholar
  132. 132.
    Jennings RW, LaQuaglia MP, Leong K, Hendren WH, Adzick NS. Fetal neuroblastoma: prenatal diagnosis and natural history. J Pediatr Surg. 1993;28:1168–74.PubMedCrossRefGoogle Scholar
  133. 133.
    Ho PT, Estroff JA, Kozakewich H, et al. Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children’s Hospital. Pediatrics. 1993;92:358–64.PubMedGoogle Scholar
  134. 134.
    Saylors 3rd RL, Cohn SL, Morgan ER, Brodeur GM. Prenatal detection of neuroblastoma by fetal ultrasonography. Am J Pediatr Hematol Oncol. 1994;16:356–60.PubMedGoogle Scholar
  135. 135.
    Acharya S, Jayabose S, Kogan SJ, et al. Prenatally diagnosed neuroblastoma. Cancer. 1997;80:304–10.PubMedCrossRefGoogle Scholar
  136. 136.
    Nuchtern JG. Perinatal neuroblastoma. Semin Pediatr Surg. 2006;15:10–6.PubMedCrossRefGoogle Scholar
  137. 137.
    Holgersen LO, Subramanian S, Kirpekar M, Mootabar H, Marcus JR. Spontaneous resolution of antenatally diagnosed adrenal masses. J Pediatr Surg. 1996;31:153–5.PubMedCrossRefGoogle Scholar
  138. 138.
    Hosoda Y, Miyano T, Kimura K, et al. Characteristics and management of patients with fetal neuroblastoma. J Pediatr Surg. 1992;27:623–5.PubMedCrossRefGoogle Scholar
  139. 139.
    Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics. 1978;62:77–83.PubMedGoogle Scholar
  140. 140.
    Newton ER, Louis F, Dalton ME, Feingold M. Fetal neuroblastoma and catecholamine-induced maternal hypertension. Obstet Gynecol. 1985;65:49S–52.PubMedGoogle Scholar
  141. 141.
    Tuchman M, Morris CL, Ramnaraine ML, Bowers LD, Krivit W. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections. Pediatrics. 1985;75:324–8.PubMedGoogle Scholar
  142. 142.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics. 1987;79:203–5.PubMedGoogle Scholar
  143. 143.
    Samuel AM. PET/CT in pediatric oncology. Indian J Cancer. 2010;47:360–70.PubMedCrossRefGoogle Scholar
  144. 144.
    Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T. I-MIBG scintigraphy/SPECT versus F-FDG PET in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging. 2011;38:1648–58.Google Scholar
  145. 145.
    Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG TASk force report. J Clin Oncol. 2009;27:298–303.PubMedPubMedCentralCrossRefGoogle Scholar
  146. 146.
    Cohen SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report. J Clin Oncol. 2009;27:289–97.CrossRefGoogle Scholar
  147. 147.
    D’Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet. 1971;1:1046–9.PubMedCrossRefGoogle Scholar
  148. 148.
    Grosfeld JL, Rescorla FJ, West KW, Goldman J. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome. Semin Pediatr Surg. 1993;2:37–46.PubMedGoogle Scholar
  149. 149.
    van Noesel MM, Hahlen K, Hakvoort-Cammel FG, Egeler RM. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer. 1997;80:834–43.PubMedCrossRefGoogle Scholar
  150. 150.
    Evans AE, Chatten J, D’Angio GJ, Gerson JM, Robinson J, Schnaufer L. A review of 17 IV-S neuroblastoma patients at the Children’s Hospital of Philadelphia. Cancer. 1980;45:833–9.PubMedCrossRefGoogle Scholar
  151. 151.
    Matthay KK, Perez C, Seeger RC, et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children’s Cancer Group study. J Clin Oncol. 1998;16:1256–64.PubMedGoogle Scholar
  152. 152.
    Strother D, Shuster JJ, McWilliams N, et al. Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol. 1995;17:254–9.PubMedCrossRefGoogle Scholar
  153. 153.
    Paul SR, Tarbell NJ, Korf B, et al. Stage IV neuroblastoma in infants: long-term survival. Cancer. 1991;67:1493–7.PubMedCrossRefGoogle Scholar
  154. 154.
    Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuoblastoma: a prospective Children’s Cancer Group study. J Clin Oncol. 2000;18:1260–8.PubMedGoogle Scholar
  155. 155.
    Grosfeld JL. Neuroblastoma, chap 28. In: Grosfeld JL, O’Neill Jr JA, Coran AG, Fonkalsrud EW, editors. Pediatric surgery, vol. 1. 6th ed. Philadelphia: Mosby Inc; 2006.Google Scholar
  156. 156.
    Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Group study. J Clin Oncol. 2000;18:477–86.PubMedGoogle Scholar
  157. 157.
    Dillon PW, Whalen TV, Azizkhan RG, et al. Neonatal soft tissue sarcomas: the influence of pathology on treatment and survival. J Pediatr Surg. 1995;30:1038–41.PubMedCrossRefGoogle Scholar
  158. 158.
    Spicer RD. Neonatal sarcoma. Early Hum Dev. 2010;86:633–6.PubMedCrossRefGoogle Scholar
  159. 159.
    Orbach D, Rey A, Oberlin O, et al. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. J Clin Oncol. 2005;23:4363–71.PubMedCrossRefGoogle Scholar
  160. 160.
    Lloyd DA. Soft-tissue sarcoma. In: Puri P, editor. Chapter 78: Newborn surgery. 2nd ed. New York: Oxford University Press Inc; 2003.Google Scholar
  161. 161.
    Barr FG. Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol. 1997;19:483–91.PubMedCrossRefGoogle Scholar
  162. 162.
    Raney Jr RB, Hays DM, Tefft M, Triche TJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: JB Lippincott; 1989. p. 635–58.Google Scholar
  163. 163.
    Raney RB, Walterhouse DO, Meza JL, et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol. 2011;29:1312–8.PubMedCrossRefGoogle Scholar
  164. 164.
    Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–102.PubMedGoogle Scholar
  165. 165.
    Crist W, Gehan EA, Ragab AH, et al. The third intergroup Rhabdomyosarcoma study. J Clin Oncol. 1995;13:610–30.PubMedGoogle Scholar
  166. 166.
    Soule EH, Pritchard DJ. Fibrosarcoma in infants and children: a review of 110 cases. Cancer. 1977;40:1711–21.PubMedCrossRefGoogle Scholar
  167. 167.
    Orbach D, Rey A, Cechetto G, et al. Infantile fibrosarcoma: management based on the European experience. J Clin Oncol. 2010;28:318–23.PubMedCrossRefGoogle Scholar
  168. 168.
    Kogon B, Shehata B, Katzenstein H. Primary congenital infantile fibrosarcoma of the heart; the first confirmed case. Ann Thorac Surg. 2011;91:1276–80.PubMedCrossRefGoogle Scholar
  169. 169.
    Blocker S, Koenig J, Ternberg J. Congenital fibrosarcoma. J Pediatr Surg. 1987;22:665–70.PubMedCrossRefGoogle Scholar
  170. 170.
    Ninane J, Gosseye S, Panteon E, Claus D, Rombouts JJ, Cornu G. Congenital fibrosarcoma: preoperative chemotherapy and conservative surgery. Cancer. 1986;58:1400–6.PubMedCrossRefGoogle Scholar
  171. 171.
    Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18:184–7.PubMedCrossRefGoogle Scholar
  172. 172.
    Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t (12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153:1451–8.PubMedPubMedCentralCrossRefGoogle Scholar
  173. 173.
    Coffin CM, Dehner LP. Soft tissue tumors in first year of life: a report of 190 cases. Pediatr Pathol. 1990;10:509–26.PubMedCrossRefGoogle Scholar
  174. 174.
    Salloum E, Flamant F, Caillaud JM, et al. Diagnostic and therapeutic problems of soft tissue tumors other than rhabdomyosarcoma in infants under 1 year of age: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy. Med Pediatr Oncol. 1990;18:37–43.PubMedCrossRefGoogle Scholar
  175. 175.
    Hrabovsky EE, Othersen Jr HB, deLorimier A, Kelalis P, Beckwith JB, Takashima J. Wilms’ tumor in the neonate: a report from the National Wilms’ Tumor Study. J Pediatr Surg. 1986;21:385–7.PubMedCrossRefGoogle Scholar
  176. 176.
    Ritchey ML, Azizkhan RG, Beckwith JB, Hrabovsky EE, Haase GM. Neonatal Wilms tumor. J Pediatr Surg. 1995;30:856–9.PubMedCrossRefGoogle Scholar
  177. 177.
    Jones VS, Cohen RC. Atypical congenital mesoblastic nephroma presenting in the perinatal period. Pediatr Surg Int. 2007;23:205–9.PubMedCrossRefGoogle Scholar
  178. 178.
    Knezevich SR, Garnett JM, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58:5046–8.PubMedGoogle Scholar
  179. 179.
    Giulian BB. Prenatal ultrasonographic diagnosis of fetal renal tumors. Radiology. 1984;152:69–70.PubMedCrossRefGoogle Scholar
  180. 180.
    Yamamoto N, Yoshizako T, Uchida N, et al. Mesoblastic nephroma: a case report of prenatal detection by MR imaging. Magn Reson Med Sci. 2006;5:47–50.PubMedCrossRefGoogle Scholar
  181. 181.
    Riccabona M. Imaging of renal tumours in infancy and childhood. Eur Radiol. 2003;13:L116–29.PubMedCrossRefGoogle Scholar
  182. 182.
    Lakhoo K, Sowerbutts H. Neonatal tumours. Pediatr Surg Int. 2010;26:1159–68.PubMedCrossRefGoogle Scholar
  183. 183.
    Leclair MD, El-Ghoneimi A, Audry G, et al. The outcome of prenatally diagnosed renal tumors. J Urol. 2005;173:186–9.PubMedCrossRefGoogle Scholar
  184. 184.
    Gonzalez-Crussi F, Sotelo-Avila C, Kidd JM. Malignant mesenchymal nephroma of infancy: report of a case with pulmonary metastases. Am J Surg Pathol. 1980;4:185–90.PubMedCrossRefGoogle Scholar
  185. 185.
    Ahmed HU, Arya M, Levitt G, et al. Part II: treatment of primary malignant non-Wilms’ renal tumours in children. Lancet Oncol. 2007;8:842–8.PubMedCrossRefGoogle Scholar
  186. 186.
    Machin GA. Persistent renal blastoma (nephroblastomatosis) as a frequent precursor of Wilms’ tumor: a pathological and clinical review. Part 2. Significance of nephroblastomatosis in the genesis of Wilms’ tumor. Am J Pediatr Hematol Oncol. 1980;2:253–61.PubMedGoogle Scholar
  187. 187.
    Riccardi VM, Sujansky E, Smith AC, Francke U. Chromosomal imbalance in the Aniridia-Wilms’ tumor association: 11p interstitial deletion. Pediatrics. 1978;61:604–10.PubMedGoogle Scholar
  188. 188.
    Weksberg R, Squire JA. Molecular biology of Beckwith-Wiedemann syndrome. Med Pediatr Oncol. 1996;27:462–9.PubMedCrossRefGoogle Scholar
  189. 189.
    Greenberg F, Stein F, Greisch MV, et al. The Perlman familial nephroblastomatosis syndrome. Am J Med Genet. 1986;24:101–10.PubMedCrossRefGoogle Scholar
  190. 190.
    Perlman M. Perlman syndrome: familial renal dysplasia with Wilms’ tumor, fetal gigantism, and multiple congenital anomalies. Am J Med Genet. 1986;25:793–5.PubMedCrossRefGoogle Scholar
  191. 191.
    Grundy P, Telzerow P, Moksness J, Breslow NE. Clinicopathologic correlates of loss of heterozygosity in Wilms’ tumor: a preliminary analysis. Med Pediatr Oncol. 1996;27:429–33.PubMedCrossRefGoogle Scholar
  192. 192.
    Beckwith JB. Mesenchymal renal neoplasms of infancy. J Pediatr Surg. 1970;5:405–6.PubMedCrossRefGoogle Scholar
  193. 193.
    Bianchi DW, Crombleholme TM, D’Alton ME, Malone FD, editors. Fetology. Diagnosis and management of the fetal patient. 2nd ed. New York: McGraw-Hill Co, Inc; 2010. Chap 116.Google Scholar
  194. 194.
    Glick RD, Hicks MJ, Nuchtern JG, et al. Renal tumors in infants less than 6 months of age. J Pediatr Surg. 2004;39:522–5.PubMedCrossRefGoogle Scholar
  195. 195.
    Green DM, Breslow NE, Beckwith JB, Takashima J, Kelalis P, D’Angio GJ. Treatment outcomes in patients less than two years of age with small, stage I, favorable-histology Wilms’ tumors. A report from the National Wilms’ Tumor Study. J Clin Oncol. 1993;11:91–5.PubMedGoogle Scholar
  196. 196.
    Powis M. Neonatal renal rumors. Early Hum Dev. 2010;86:607–12.PubMedCrossRefGoogle Scholar
  197. 197.
    Campbell AN, Chan HS, O’Brien A, Smith CR, Becker LE. Malignant tumors in the neonate. Arch Dis Child. 1987;62:19–23.PubMedPubMedCentralCrossRefGoogle Scholar
  198. 198.
    von Schweinitz D. Neonatal liver tumours. Semin Neonatol. 2003;8:403–10.CrossRefGoogle Scholar
  199. 199.
    Douri T. Multiple cutaneous hemangiomas accompanied by hepatic hemangiomas. Dermatol Online J. 2005;11:21.PubMedGoogle Scholar
  200. 200.
    Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr. 1996;129:346–54.PubMedCrossRefGoogle Scholar
  201. 201.
    Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37:517–84.PubMedCrossRefGoogle Scholar
  202. 202.
    Horii KA, Drolet BA, Frieden IJ, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol. 2011;28:245–53.PubMedCrossRefGoogle Scholar
  203. 203.
    Marler JJ, Fishman SJ, Upton J, et al. Prenatal diagnosis of vascular anomalies. J Pediatr Surg. 2002;37:318–26.PubMedCrossRefGoogle Scholar
  204. 204.
    Kassarjian A, Zurakowski D, Dubois J, Paltiel HJ, Fishman SJ, Burrows PE. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. Am J Roentgenol. 2004;182:785–95.CrossRefGoogle Scholar
  205. 205.
    Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med. 2000;343:185–9.PubMedCrossRefGoogle Scholar
  206. 206.
    Kassarjian A, Dubois J, Burrows PE. Angiographic classification of hepatic hemangiomas in infants. Radiology. 2002;222:693–8.PubMedCrossRefGoogle Scholar
  207. 207.
    Azizkhan RG, Cohen AP, Dasgupta R, Adams D. Vascular anomalies, chap 75. In: Ziegler M, Azizkhan R, Weber T, von Allmen D, editors. Operative pediatric surgery. 2nd ed. McGraw-Hill; China: 2014, in press.Google Scholar
  208. 208.
    Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998;132:527–30.PubMedCrossRefGoogle Scholar
  209. 209.
    Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJ. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope. 2004;114:1231–6.PubMedCrossRefGoogle Scholar
  210. 210.
    Yoon SS, Charny CK, Fong Y, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg. 2003;197:392–402.PubMedCrossRefGoogle Scholar
  211. 211.
    Tiao GM, Alonso M, Bezerra J, et al. Liver transplantation in children younger than 1 year—the Cincinnati experience. J Pediatr Surg. 2005;40:268–73.PubMedCrossRefGoogle Scholar
  212. 212.
    Makin E, Davenport M. Fetal and neonatal liver tumours. Early Hum Dev. 2010;86:637–42.PubMedCrossRefGoogle Scholar
  213. 213.
    Stringer MD, Alizai NK. Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg. 2005;40:1681–90.PubMedCrossRefGoogle Scholar
  214. 214.
    Ramanujam TM, Ramesh JC, Goh DW, et al. Malignant transformation of mesenchymal hamartoma of the liver: case report and review of the literature. J Pediatr Surg. 1999;34:1684–6.PubMedCrossRefGoogle Scholar
  215. 215.
    Isaacs Jr H. Liver tumors. In: Isaacs Jr H, editor. Tumors of the fetus and newborn. Philadelphia: WB Saunders; 1991. p. 275–97.Google Scholar
  216. 216.
    Hartley AL, Birch JM, Kelsey AM, et al. Epidemiological and familial aspects of hepatoblastoma. Med Pediatr Oncol. 1990;18:103–9.PubMedCrossRefGoogle Scholar
  217. 217.
    Berry CL, Keeling J, Hilton C. Coincidence of congenital malformation and embryonic tumours of childhood. Arch Dis Child. 1970;45:229–31.PubMedPubMedCentralCrossRefGoogle Scholar
  218. 218.
    Fraumeni Jr JF, Miller RW. Adrenocortical neoplasms with hemihypertrophy, brain tumors, and other disorders. J Pediatr. 1967;70:129–38.PubMedCrossRefGoogle Scholar
  219. 219.
    Sotelo-Avila C, Gooch 3rd WM. Neoplasms associated with the Beckwith-Wiedemann syndrome. Perspect Pediatr Pathol. 1976;3:255–72.PubMedGoogle Scholar
  220. 220.
    Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987;328:614–6.PubMedCrossRefGoogle Scholar
  221. 221.
    Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review. Cancer. 1998;82:1789–96.PubMedCrossRefGoogle Scholar
  222. 222.
    Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: a trend or a chance? J Pediatr. 1997;130:557–60.PubMedCrossRefGoogle Scholar
  223. 223.
    Tanimura M, Matsui I, Abe J, et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res. 1998;58:3032–5.PubMedGoogle Scholar
  224. 224.
    Cremin BJ, Nuss D. Calcified hepatoblastoma in a newborn. J Pediatr Surg. 1974;9:913–5.PubMedCrossRefGoogle Scholar
  225. 225.
    Sinta L, Freud N, Dulitzki F. Hemoperitoneum as the presenting sign of hepatoblastoma in a newborn. Pediatr Surg Int. 1992;7:131–3.CrossRefGoogle Scholar
  226. 226.
    Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000;18:2665–75.PubMedGoogle Scholar
  227. 227.
    Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin and delayed surgery for childhood hepatoblastoma: a successful approach—results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol. 2000;18:3819–28.PubMedGoogle Scholar
  228. 228.
    Fuchs J, Rydzynski J, Hecker H, et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma: a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg. 2002;12:255–61.PubMedCrossRefGoogle Scholar
  229. 229.
    Fuchs J, Rydzynski J, von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report form the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer. 2002;95:172–82.PubMedCrossRefGoogle Scholar
  230. 230.
    Gonzalez-Crussi F, Upton MP, Maurer HS. Hepatoblastoma: attempt at characterization of histologic subtypes. Am J Surg Pathol. 1982;6:599–612.PubMedCrossRefGoogle Scholar
  231. 231.
    Salim A, Wiknjosastro GH, Danukusumo D, Barnas B, Zalud I. Fetal retinoblastoma. J Ultrasound Med. 1998;17:717–20.PubMedGoogle Scholar
  232. 232.
    Donaldson SS, Egbert PR, Lee WH. Retinoblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott; 1993. p. 683–96.Google Scholar
  233. 233.
    Shields JA, Shields CL. Update on retinoblastoma. Semin Ophthalmol. 1990;5:183–92.CrossRefGoogle Scholar
  234. 234.
    Shields JA, Shields CL. Current management of retinoblastoma. Mayo Clin Proc. 1994;69:50–6.PubMedCrossRefGoogle Scholar
  235. 235.
    Dudgeon J. Retinoblastoma: trends in conservative management. Br J Ophthalmol. 1995;79:104.PubMedPubMedCentralCrossRefGoogle Scholar
  236. 236.
    Lamkin TD, Gamis AS. Neonatal oncology, chap 16. In: de Alarcon PA, Werner E, editors. Neonatal hematology. New York: Cambridge University Press; 2005.Google Scholar
  237. 237.
    Doz F, Neuenschwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d’Oncologie Pédiatrique. J Clin Oncol. 1995;13:902–9.PubMedGoogle Scholar
  238. 238.
    Pratt CB, Fontanesi J, Chenaille P, et al. Chemotherapy for extraocular retinoblastoma. Pediatr Hematol Oncol. 1994;11:301–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Department of Pediatric SurgeryCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Department of SurgeryCincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations